IMPACT OF MUMIJO (SHILAJIT) ON BLOOD COAGULATION PARAMETERS IN CHRONIC DOG EXPERIMENTS
Keywords:
Mumiyo, blood coagulation, hemostasis, anticoagulant activity, fibrinolysis, coagulation factors, chronic experiment.Abstract
The present study investigated the effects of chronic administration of mumiyo at a dose of 100 mg/kg on the blood coagulation system in dogs. Five healthy adult animals were monitored over six days, and coagulation parameters were assessed at baseline and on days 3, 5, and 6. Mumiyo administration produced a significant prolongation of blood clotting time, plasma recalcification time, thrombin time, and heparin time, indicating a marked reduction in overall coagulation activity. Plasma tolerance to heparin increased progressively, suggesting enhanced sensitivity to anticoagulant modulation. Coagulation factors II and V exhibited time-dependent changes, with Factor II increasing steadily and Factor V showing an initial decrease followed by significant elevation. Fibrinogen levels increased moderately, while fibrinolytic activity decreased, reflecting slower clot degradation. Collectively, these findings demonstrate that mumiyo shifts hemostasis toward a hypocoagulable state and promotes the formation of looser, less stable clots. The results suggest potential anticoagulant properties of mumiyo and support the need for further studies to elucidate its mechanisms of action and therapeutic applicability.
Downloads
References
1. Ghosal S. 2006. Shilajit in Perspective. Narosa Publishing House, New Delhi India.
2. Olivieri MF, Marzari F, Kesel AJ, Bonalume L, Saettini F. Pharmacology and psychiatry at the origins of Greek medicine: The myth of Melampus and the madness of the Proetides. J Hist Neurosci. 2017;26(2):193-215.
3. Wilson E, Rajamanickam GV, Dubey GP,et al.2011. Review on shilajit used in traditional Indian medicine.J Ethnopharmacol 136:1–9
4. Schepetkin I, Khebnikov A, Kwon BS. 2002. Medical drugs from humus matter: focus on mumie.Drug Devel Res57: 140–159
5. Shirbeigi L ZA, Naghizadeh A, Alizadeh Vaghasloo M. The Concept of Temperaments in Traditional Persian Medicine. Trad Integr Med. 2017;2(3):143-56.
6. Frolova N, Kiseleva L, Tatiana. Chemical composition of mumijo and methods for determining its authenticity and quality (a review). Pharma Chem J. 1996;30(8):543-7.
7. Agarwal SP, Khanna R, Karmarkar R, Anwer MK, Khar RK. Shilajit: a review. Phytother Res. 2007;21(5):401-5.
8. Verma A, Kumar N, Gupta L, Chaudhary S. Shilajitin Cancer Treatment: Probable Mode of Action. Int J Pharmaceutic Bio Arch. 2016;7(1):12-6.
9. Stohs SJ, Singh K, Das A, Roy S, Sen CK. 12-Energy and Health Benefits of Shilajit. In: Bagchi D, editor. Sustained Energy for Enhanced Human Functions and Activity. Academic Press; 2017. p. 187-204
10. Ghosal S, Lal J, Singh SK, Goel RK, Jaiswal AK, Bhattacharya SK. The need for formulation of Shilajit by its isolated active constituents. Phytother Res. 1991;5(5):211-6
11. Trivedi N, Mazumdar B, Bhatt J, Hemavathi K. Effect of shilajit on blood glucose and lipid profile in alloxaninduced diabetic rats. Indian J Pharmacol. 2004;36(6):373-6.
12. Загрутдинов Ф.Ф., Мамадалиев Ш.И., Болтабоева Д.Ф. Влияние Среднеазиатских Видов Мумиё на диурез и натрий урез у Крыс. Open Herald: Periodical of Methodical Research. Volume 2, Issue 5, May, 2024, 12-14
